» Articles » PMID: 11157072

Growth Arrest of Individual Senile Plaques in a Model of Alzheimer's Disease Observed by in Vivo Multiphoton Microscopy

Overview
Journal J Neurosci
Specialty Neurology
Date 2001 Feb 7
PMID 11157072
Citations 82
Authors
Affiliations
Soon will be listed here.
Abstract

In Alzheimer's disease, amyloid-beta peptide aggregates in the extracellular space to form senile plaques. The process of plaque deposition and growth has been modeled on the basis of in vitro experiments in ways that lead to divergent predictions: either a diffusion-limited growth model in which plaques grow by first-order kinetics, or a dynamic model of continual deposition and asymmetrical clearance in which plaques reach a stable size and stop growing but evolve morphologically over time. The models have not been tested in vivo because plaques are too small (by several orders of magnitude) for conventional imaging modalities. We now report in vivo multiphoton laser scanning imaging of thioflavine S-stained senile plaques in the Tg2576 transgenic mouse model of Alzheimer's disease to test these biophysical models and show that there is no detectable change in plaque size over extended periods of time. Qualitatively, geometric features remain unchanged over time in the vast majority of the 349 plaques imaged and re-imaged. Intervals as long as 5 months were obtained. Nonetheless, rare examples of growth or shrinkage of individual plaques do occur, and new plaques appear between imaging sessions. These results indicate that thioflavine S-positive plaques appear and then are stable, supporting a dynamic feedback model of plaque growth.

Citing Articles

Viscocohesive hyaluronan gel enhances stability of intravital multiphoton imaging with subcellular resolution.

Morton R, Kim T Neurophotonics. 2024; 12(Suppl 1):S14602.

PMID: 39583344 PMC: 11582905. DOI: 10.1117/1.NPh.12.S1.S14602.


VE-cadherin in arachnoid and pia mater cells serves as a suitable landmark for in vivo imaging of CNS immune surveillance and inflammation.

Mapunda J, Pareja J, Vladymyrov M, Bouillet E, Helie P, Pleskac P Nat Commun. 2023; 14(1):5837.

PMID: 37730744 PMC: 10511632. DOI: 10.1038/s41467-023-41580-4.


Long-Term Repeatable In Vivo Monitoring of Amyloid-β Plaques and Vessels in Alzheimer's Disease Mouse Model with Combined TPEF/CARS Microscopy.

Luo Z, Xu H, Samanta S, Zhang R, Luo G, Wang Y Biomedicines. 2022; 10(11).

PMID: 36428517 PMC: 9687891. DOI: 10.3390/biomedicines10112949.


A Model of Discovery: The Role of Imaging Established and Emerging Non-mammalian Models in Neuroscience.

Haynes E, Ulland T, Eliceiri K Front Mol Neurosci. 2022; 15:867010.

PMID: 35493325 PMC: 9046975. DOI: 10.3389/fnmol.2022.867010.


Optical Imaging of Beta-Amyloid Plaques in Alzheimer's Disease.

Luo Z, Xu H, Liu L, Ohulchanskyy T, Qu J Biosensors (Basel). 2021; 11(8).

PMID: 34436057 PMC: 8392287. DOI: 10.3390/bios11080255.


References
1.
Schenk D, Barbour R, Dunn W, Gordon G, Grajeda H, Guido T . Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature. 1999; 400(6740):173-7. DOI: 10.1038/22124. View

2.
Mirra S, HEYMAN A, McKeel D, SUMI S, Crain B, Brownlee L . The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology. 1991; 41(4):479-86. DOI: 10.1212/wnl.41.4.479. View

3.
Vonsattel J, Myers R, Hedley-Whyte E, Ropper A, BIRD E, Richardson Jr E . Cerebral amyloid angiopathy without and with cerebral hemorrhages: a comparative histological study. Ann Neurol. 1991; 30(5):637-49. DOI: 10.1002/ana.410300503. View

4.
Frautschy S, Yang F, Irrizarry M, Hyman B, Saido T, Hsiao K . Microglial response to amyloid plaques in APPsw transgenic mice. Am J Pathol. 1998; 152(1):307-17. PMC: 1858113. View

5.
Esler W, Stimson E, Ghilardi J, Vinters H, Lee J, Mantyh P . In vitro growth of Alzheimer's disease beta-amyloid plaques displays first-order kinetics. Biochemistry. 1996; 35(3):749-57. DOI: 10.1021/bi951685w. View